- American Association of Neuropathologists
- Association for Molecular Pathology
Kimmo Hatanpaa, M.D., Ph.D.
- Pathology
- Diagnostic Neuropathology
Education & Training
- Fellowship - National Institute on Aging (1993-1998), Neuroscience
- Residency - Yale-New Haven Hospital (1998-2000), Anatomic Pathology
- Fellowship - Johns Hopkins School of Medicine (2000-2002), Neuropathology
- Medical Education - University of Tampere (1985-1991)
- Other - University of Tampere School of Medicine (1993-1999), Doctor of Philosophy Pathology
- Other - University of Tampere School of Medicine (1993-1999), Doctor of Philosophy
Professional Associations & Affiliations
Honors & Awards
- American Association of Neuropathologists 2010, Moore Award for the Best Paper on Clinico-Pathological Correlation, honorable mention
Books & Publications
-
Publications
-
Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.
Chkheidze R, Raisanen J, Gagan J, Richardson TE, Pinho MC, Raj K, Achilleos M, Slepicka C, White CL, Evers BM, Patel TR, Malter JS, Hatanpaa KJ, Journal of neuropathology and experimental neurology 2021 Dec 80 12 1092-1098 -
Neurological infections in 2020: COVID-19 takes centre stage.
Fredrich S, Greenberg BM, Hatanpaa KJ, The Lancet. Neurology 2021 Jan 20 1 17-18 -
Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival.
Richardson TE, Patel S, Serrano J, Sathe AA, Daoud EV, Oliver D, Maher EA, Madrigales A, Mickey BE, Taxter T, Jour G, White CL, Raisanen JM, Xing C, Snuderl M, Hatanpaa KJ, Journal of neuropathology and experimental neurology 2019 Apr -
Spinal Pleomorphic Xanthoastrocytoma With a QKI-RAF1 Fusion.
Daoud EV, Wachsmann M, Richardson TE, Mella D, Pan E, Schwarzbach A, Oliver D, Hatanpaa KJ Journal of neuropathology and experimental neurology 2019 Jan 78 1 10-14 -
BRAF mutation leading to central nervous system Rosai-Dorfman disease.
Richardson TE, Wachsmann M, Oliver D, Abedin Z, Ye D, Burns DK, Raisanen JM, Greenberg BM, Hatanpaa KJ Annals of neurology 2018 Jul -
Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas.
Richardson TE, Sathe AA, Kanchwala M, Jia G, Habib AA, Xiao G, Snuderl M, Xing C, Hatanpaa KJ Journal of neuropathology and experimental neurology 2018 May -
Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.
Daoud EV, Rajaram V, Cai C, Oberle RJ, Martin GR, Raisanen JM, White CL, Foong C, Mickey BE, Pan E, Hatanpaa KJ Journal of neuropathology and experimental neurology 2018 Feb -
A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma.
Guo G, Gong K, Ali S, Ali N, Shallwani S, Hatanpaa KJ, Pan E, Mickey B, Burma S, Wang DH, Kesari S, Sarkaria JN, Zhao D, Habib AA Nature neuroscience 2017 Jun -
Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis.
Richardson TE, Snuderl M, Serrano J, Karajannis MA, Heguy A, Oliver D, Raisanen JM, Maher EA, Pan E, Barnett S, Cai C, Habib AA, Bachoo RM, Hatanpaa KJ Journal of neuro-oncology 2017 Apr -
Unusual skull tumors with psammomatoid bodies: a diagnostic challenge.
Richardson TE, Georgescu MM, Kapur P, Hwang H, Barnett SL, Raisanen JM, Cai C, Hatanpaa KJ Clinical neuropathology 2017 Jan -
Clinical Outcome of Silent Subtype III Pituitary Adenomas Diagnosed by Immunohistochemistry.
Richardson TE, Mathis DA, Mickey BE, Raisanen JM, Burns DK, White CL, Hatanpaa KJ Journal of neuropathology and experimental neurology 2015 Dec 74 12 1170-7 -
Lymphomatosis Cerebri: A Diagnostic Challenge.
Hatanpaa KJ, Fuda F, Koduru P, Young K, Lega B, Chen W JAMA neurology 2015 Jul -
High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas.
Hatanpaa KJ, Hu T, Vemireddy V, Foong C, Raisanen JM, Oliver D, Hiemenz MC, Burns DK, White CL, Whitworth LA, Mickey B, Stegner M, Habib AA, Fink K, Maher EA, Bachoo RM Journal of neuro-oncology 2014 Mar 117 1 183-9 -
Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields.
Hatanpaa KJ, Raisanen JM, Herndon E, Burns DK, Foong C, Habib AA, White CL Journal of neuropathology and experimental neurology 2014 Feb 73 2 136-42 -
Neuropathology of viral infections.
Hatanpaa KJ, Kim JH Handbook of clinical neurology 2014 123 193-214 -
Epidermal growth factor receptor (EGFR) in glioma: signal transduction, neuropathology, imaging and radioresistance
Hatanpaa KJ, Burma S, Zhao D, and Habib AA Neoplasia 2010 12(9) 675-84 -
Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer’s disease without conventional Lewy body pathology
Lewis KA, Su Y, Jou O, Ritchie C, Foong C, Hynan LS, White CL 3rd, Thomas PJ, and Hatanpaa KJ Am J Pathol 2010 177(6): 3037-3050 -
TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study
Hatanpaa KJ, Bigio EH, Cairns NJ, Womack KB, Weintraub S, Morris JC, Foong C, Xiao G, Hladik C, Mantanona TY, White CL 3rd J Neuropathol Exp Neurol 2008 67(4) 271-9 -
Molecular diagnosis of oligodendroglioma in paraffin sections
Hatanpaa KJ, Burger PC, Eshleman JR, Berg KD Lab Invest 2003 83(3) 419-428
-
Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.
Research
- Brain tumors
- Neurodegenerative diseases
Clinical Focus
- Diagnostic Neuropathology